Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 76% ± 13% | |
lung | 18 studies | 67% ± 20% | |
brain | 14 studies | 35% ± 17% | |
intestine | 12 studies | 61% ± 25% | |
eye | 10 studies | 46% ± 20% | |
kidney | 9 studies | 70% ± 18% | |
bone marrow | 6 studies | 56% ± 24% | |
liver | 6 studies | 59% ± 14% | |
lymph node | 5 studies | 76% ± 18% | |
uterus | 5 studies | 68% ± 26% | |
prostate | 5 studies | 48% ± 22% | |
pancreas | 4 studies | 68% ± 22% | |
placenta | 4 studies | 71% ± 19% | |
skin | 4 studies | 45% ± 24% | |
breast | 4 studies | 74% ± 11% | |
heart | 3 studies | 37% ± 16% | |
adrenal gland | 3 studies | 67% ± 15% | |
esophagus | 3 studies | 62% ± 23% | |
thymus | 3 studies | 76% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 11145.47 | 258 / 258 | 100% | 230.59 | 230 / 230 |
esophagus | 100% | 9090.21 | 1445 / 1445 | 100% | 115.41 | 183 / 183 |
ovary | 100% | 10535.96 | 180 / 180 | 100% | 255.91 | 430 / 430 |
pancreas | 100% | 7897.80 | 328 / 328 | 100% | 185.20 | 178 / 178 |
skin | 100% | 10201.81 | 1809 / 1809 | 100% | 269.91 | 472 / 472 |
thymus | 100% | 7819.70 | 653 / 653 | 100% | 211.45 | 605 / 605 |
uterus | 100% | 9171.81 | 170 / 170 | 100% | 233.13 | 459 / 459 |
brain | 100% | 7720.39 | 2639 / 2642 | 100% | 201.06 | 705 / 705 |
kidney | 100% | 11090.46 | 89 / 89 | 100% | 225.55 | 899 / 901 |
intestine | 100% | 11472.74 | 966 / 966 | 100% | 201.90 | 525 / 527 |
prostate | 100% | 9801.87 | 245 / 245 | 100% | 305.03 | 500 / 502 |
liver | 100% | 5353.48 | 225 / 226 | 100% | 177.58 | 406 / 406 |
stomach | 100% | 9354.07 | 359 / 359 | 99% | 170.52 | 284 / 286 |
breast | 100% | 9250.42 | 459 / 459 | 99% | 246.41 | 1106 / 1118 |
bladder | 100% | 9960.76 | 21 / 21 | 99% | 216.37 | 498 / 504 |
lung | 100% | 7450.38 | 576 / 578 | 99% | 184.03 | 1141 / 1155 |
adipose | 100% | 8540.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 507.18 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 346.08 | 29 / 29 |
muscle | 100% | 17566.55 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9931.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 189.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 266.32 | 1 / 1 |
blood vessel | 100% | 7904.31 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 12349.65 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 8033.15 | 900 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0000276 | Cellular component | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0015078 | Molecular function | proton transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
Gene name | ATP5MC2 |
Protein name | ATP synthase membrane subunit c locus 2 ATP synthase F(0) complex subunit C2, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 2) (ATP synthase proteolipid P2) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C2) (ATPase protein 9) (ATPase subunit c) |
Synonyms | ATP5G2 PSEC0033 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. A homomeric c-ring of probably 10 subunits is part of the complex rotary element. |
Accessions | F8W041 ENST00000549164.5 [Q06055-1] Q06055 ENST00000673498.1 [Q06055-3] ENST00000338662.6 [Q06055-1] ENST00000552242.5 [Q06055-1] ENST00000394349.9 [Q06055-1] ENST00000549748.2 |